Filing Details
- Accession Number:
- 0001179110-10-003973
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-26 12:00:00
- Reporting Period:
- 2010-02-24
- Filing Date:
- 2010-02-26
- Accepted Time:
- 2010-02-26 17:54:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190273 | W Norbert Bischofberger | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, R&D And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-02-24 | 6,246 | $16.01 | 1,038,482 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2010-02-24 | 53,754 | $16.01 | 1,092,236 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-02-24 | 53,754 | $47.49 | 1,038,482 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2010-02-24 | 6,246 | $0.00 | 6,246 | $16.01 |
| Common Stock | Non-qualified Stock Option (right to buy) | Disposition | 2010-02-24 | 53,754 | $0.00 | 53,754 | $16.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-01-26 | No | 4 | M | Direct | |
| 0 | 2015-01-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,794 | Indirect | by Trust |
| Common Stock | 1,600 | Indirect | by Son |
| Common Stock | 1,600 | Indirect | by Daughter |
Footnotes
- Sale prices reported for the transactions reported here range from $47.45 to $47.51. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- The options had a five year vesting schedule. 20% of the options vested on January 26, 2006, the first anniversary date of the grant. The balance vested 5% every three months thereafter until fully vested on January 26, 2010.
Billionaire Hedge Funds
